Table 1.
Hospital Charges as Incurred, Costs as Incurred, and Costs in 2012 US Currency for the Initial Treatment of US Patients with Moderate or Severe Stroke Enrolled in the Study†
Treatment Group |
Charges (Year of Stroke*) |
Costs (Year of Stroke*) |
Present Value Costs (2012 Value) |
Estimated Mean 2012 Cost** |
---|---|---|---|---|
Endovascular Therapy: | ||||
Mean (SD) | $113,185 (82,797) | $31,074 (18,756) | $35,175 (20,702) | $35,130 |
Median (Range) | $86,481 (23,350–552,279) | $26,935 (6,602–179,491) | $29,848 (7,856–205,609) | |
IV t-PA Alone: | ||||
Mean (SD) | $86,880 (91,057) | $23,833 (21,799) | $26,266 (24,042) | $25,630 |
Median (Range) | $58,247 (13,701–830,652) | $18,134 (6,602–179,491) | $19,768 (5,992–209,299) |
No physician charges are included in the estimates.
IV = intravenous; t-PA = tissue plasminogen activator;
Costs in year of stroke indicates the actual costs at the time of patient enrollment. These costs are not adjusted for inflation.
Multivariable model controlling for age, NIHSS, time to IV t-PA administration, stroke location and diabetes.